Adam Woodrow Paratek Pharmaceuticals, Inc. (PRTK) insider trading activity

Adam Woodrow is President & Chief Commercial of Paratek Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of PRTK, which is worth approximately $0. The most recent transaction as insider was on Sep 21, 2023, when has been sold 749,034 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Adam Woodrow Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 21 2023	SELL Sale (or disposition) back to the issuer	-	749,034 Reduced 100.0%	0 Common Stock
Aug 08 2023	BUY Grant, award, or other acquisition	-	98,750 Added 11.63%	750,034 Common Stock
Dec 21 2022	SELL Open market or private sale	$13,432 $1.99 p/Share	6,750 Reduced 1.03%	651,284 Common Stock
Dec 20 2022	BUY Grant, award, or other acquisition	-	22,500 Added 3.31%	658,034 Common Stock
Dec 13 2022	SELL Open market or private sale	$12,255 $1.96 p/Share	6,253 Reduced 0.97%	635,534 Common Stock
Dec 12 2022	SELL Open market or private sale	$7,563 $1.98 p/Share	3,820 Reduced 0.59%	641,787 Common Stock
Oct 28 2022	SELL Open market or private sale	$15,833 $3.47 p/Share	4,563 Reduced 0.7%	645,607 Common Stock

Oct 25 2022	BUY Grant, award, or other acquisition	-	15,000 Added 2.26%	650,170 Common Stock
Aug 08 2022	BUY Grant, award, or other acquisition	-	71,591 Added 10.13%	635,170 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	101,250 Added 15.23%	563,579 Common Stock
Dec 15 2021	SELL Open market or private sale	$96,604 $4.27 p/Share	22,624 Reduced 4.67%	462,329 Common Stock
Dec 14 2021	SELL Open market or private sale	$47,834 $4.37 p/Share	10,946 Reduced 2.21%	484,953 Common Stock
Dec 13 2021	SELL Open market or private sale	$28,385 $4.42 p/Share	6,422 Reduced 1.28%	494,899 Common Stock
Aug 17 2021	SELL Open market or private sale	$56,192 $5.12 p/Share	10,975 Reduced 2.14%	501,321 Common Stock
Aug 16 2021	BUY Grant, award, or other acquisition	-	37,500 Added 6.82%	512,296 Common Stock
Jun 04 2021	SELL Open market or private sale	$166,665 $9.7 p/Share	17,182 Reduced 3.49%	474,796 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	42,955 Added 8.03%	491,978 Common Stock
Mar 30 2021	BUY Grant, award, or other acquisition	-	177,750 Added 28.36%	449,023 Common Stock
Dec 14 2020	SELL Open market or private sale	$86,257 $6.71 p/Share	12,855 Reduced 4.52%	271,273 Common Stock
Dec 11 2020	SELL Open market or private sale	$62,863 $6.95 p/Share	9,045 Reduced 3.09%	284,128 Common Stock
Nov 13 2020	SELL Open market or private sale	$88,950 $5.93 p/Share	15,000 Reduced 4.87%	293,173 Common Stock
Nov 12 2020	BUY Grant, award, or other acquisition	-	37,500 Added 10.85%	308,173 Common Stock

Adam Woodrow

President & Chief Commercial

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRTK shares.

Notify only if

Value

Insider Trading

Get notified when an Paratek Pharmaceuticals, Inc. insider buys or sells PRTK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Paratek Pharmaceuticals, Inc.

Track Activities on PRTK

Account